CAFs-derived Wnt2 showed significant association with lymph node metastasis and short median survival time (Wnt2-positive ESCC vs Wnt2-negative ESCC, 16 vs. 51 months). This evidence concerns the gene WNT2 and metastatic malignant neoplasm in the lymph nodes.